Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Anthony Traboulsee, Benjamin Greenberg, Jeffrey L. Bennett, L Szczechowski, Edward Fox, Svitlana Shkrobot, Takashi Yamamura, Yusuke Terada, Yuichi Kawata, Pádraig Wright, Athos Gianella-Borradori, Hideki Garren, Brian G. Weinshenker
Topics & Concepts
MedicinePlaceboClinical endpointPopulationNeuromyelitis opticaInternal medicineClinical trialIntention-to-treat analysisPediatricsAntibodyImmunologyPathologyEnvironmental healthAlternative medicineMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSystemic Sclerosis and Related Diseases